Khurram Jamil

CIK: 0002032345

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)18 (48.6%)

Position reduction

Option Exercises (M)15 (40.5%)

Derivative conversions

Awards (A)4 (10.8%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GALT

GALECTIN THERAPEUTICS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (37 total)

GALT
GALECTIN THERAPEUTICS INC
Jul 14, 2026
Sale(S)
Direct
16.3K shares at avg. $5.13$83K
GALT
GALECTIN THERAPEUTICS INC
Jul 14, 2026
Exercise(M)
Direct
16.3K shares at avg. $3.04$49K
GALT
GALECTIN THERAPEUTICS INC
Jun 29, 2026
Sale(S)
Direct
47.5K shares at avg. $5.04$239K
GALT
GALECTIN THERAPEUTICS INC
Jun 29, 2026
Exercise(M)
Direct
47.5K shares at avg. $2.50$119K
GALT
GALECTIN THERAPEUTICS INC
Jun 26, 2026
Sale(S)
Direct
2K shares at avg. $5.00$10K
GALT
GALECTIN THERAPEUTICS INC
Jun 26, 2026
Exercise(M)
Direct
2.5K shares at avg. $2.50$6K
GALT
GALECTIN THERAPEUTICS INC
Jun 26, 2026
Exercise(M)
Direct
2K shares at avg. $2.20$4K
GALT
GALECTIN THERAPEUTICS INC
Jun 26, 2026
Sale(S)
Direct
2.5K shares at avg. $5.00$13K
GALT
GALECTIN THERAPEUTICS INC
Jun 23, 2026
Exercise(M)
Direct
7.6K shares at avg. $1.23$9K
GALT
GALECTIN THERAPEUTICS INC
Jun 23, 2026
Sale(S)
Direct
7.6K shares at avg. $3.14$24K
GALT
GALECTIN THERAPEUTICS INC
May 26, 2026
Sale(S)
Direct
568 shares at avg. $3.10$2K
GALT
GALECTIN THERAPEUTICS INC
May 26, 2026
Exercise(M)
Direct
568 shares at avg. $1.23$698.64
GALT
GALECTIN THERAPEUTICS INC
Jan 16, 2026
Award(A)
Restricted Stock Unit
Direct
100K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 16, 2026
Award(A)
Stock option (right to buy)
Direct
65K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 6, 2026
Sale(S)
Direct
21.4K shares at avg. $3.65$78K
GALT
GALECTIN THERAPEUTICS INC
Jan 5, 2026
Sale(S)
Direct
25.5K shares at avg. $3.90$99K
GALT
GALECTIN THERAPEUTICS INC
Jan 2, 2026
Sale(S)
Direct
13.1K shares at avg. $4.20$55K
GALT
GALECTIN THERAPEUTICS INC
Jan 2, 2026
Exercise(M)
Direct
60K shares-
GALT
GALECTIN THERAPEUTICS INC
Jan 1, 2026
Exercise(M)
Restricted Stock Unit
Direct
60K shares-
GALT
GALECTIN THERAPEUTICS INC
Dec 31, 2025
Exercise(M)
Direct
8.1K shares at avg. $1.23$10K
GALT
GALECTIN THERAPEUTICS INC
Dec 31, 2025
Sale(S)
Direct
8.1K shares at avg. $4.07$33K
GALT
GALECTIN THERAPEUTICS INC
Dec 17, 2025
Exercise(M)
Direct
8.5K shares at avg. $2.50$21K
GALT
GALECTIN THERAPEUTICS INC
Dec 17, 2025
Sale(S)
Direct
6.5K shares at avg. $7.04$45K
GALT
GALECTIN THERAPEUTICS INC
Dec 17, 2025
Exercise(M)
Direct
6.5K shares at avg. $2.20$14K
GALT
GALECTIN THERAPEUTICS INC
Dec 17, 2025
Sale(S)
Direct
4.5K shares at avg. $7.04$32K

		Type	Shares	Price		Ownership
Jul 14, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	16,250	$5.13	$83,285	Direct
Jul 14, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	16,250	$3.04	$49,400	Direct
Jun 29, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	47,467	$5.04	$239,234	Direct
Jun 29, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	47,467	$2.50	$118,668	Direct
Jun 26, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	2,037	$5.00	$10,185	Direct
Jun 26, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	2,533	$2.50	$6,333	Direct
Jun 26, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	2,037	$2.20	$4,481	Direct
Jun 26, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	2,533	$5.00	$12,665	Direct
Jun 23, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	7,557	$1.23	$9,295	Direct
Jun 23, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	7,557	$3.14	$23,729	Direct
May 26, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	568	$3.10	$1,761	Direct
May 26, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	568	$1.23	$699	Direct
Jan 16, 2026	GALT GALECTIN THERAPEUTICS INC	Award(A) Restricted Stock Unit	100,000	-	-	Direct
Jan 16, 2026	GALT GALECTIN THERAPEUTICS INC	Award(A) Stock option (right to buy)	65,000	-	-	Direct
Jan 6, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	21,446	$3.65	$78,205	Direct
Jan 5, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	25,499	$3.90	$99,408	Direct
Jan 2, 2026	GALT GALECTIN THERAPEUTICS INC	Sale(S)	13,055	$4.20	$54,789	Direct
Jan 2, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	60,000	-	$0	Direct
Jan 1, 2026	GALT GALECTIN THERAPEUTICS INC	Exercise(M) Restricted Stock Unit	60,000	-	-	Direct
Dec 31, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	8,125	$1.23	$9,994	Direct
Dec 31, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	8,125	$4.07	$33,089	Direct
Dec 17, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	8,500	$2.50	$21,250	Direct
Dec 17, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	6,463	$7.04	$45,500	Direct
Dec 17, 2025	GALT GALECTIN THERAPEUTICS INC	Exercise(M)	6,463	$2.20	$14,219	Direct
Dec 17, 2025	GALT GALECTIN THERAPEUTICS INC	Sale(S)	4,479	$7.04	$31,532	Direct

1-25 of 37 transactions

About Jamil Khurram

Jamil Khurram (SEC CIK 0002032345) files insider reports with the SEC as Chief Medical Officer of GALECTIN THERAPEUTICS INC (GALT).

Signal8 holds 11 ownership filings by Jamil Khurram, all Form 4s, filed between Dec 26, 2024 and Jul 16, 2026. Those filings report 37 transactions, from Dec 23, 2024 to Jul 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jamil Khurram's filings is in NORCROSS, GA.

Recent filings by Jamil Khurram

Jul 14, 2026: Open-market sale of GALT shares (Form 4, code S).
Jul 14, 2026: Option exercise of GALT shares (Form 4, code M).
Jun 29, 2026: Open-market sale of GALT shares (Form 4, code S).
Jun 29, 2026: Option exercise of GALT shares (Form 4, code M).
Jun 26, 2026: Open-market sale of GALT shares (Form 4, code S).

Other insiders filing for GALECTIN THERAPEUTICS INC (GALT)

Uihlein Richard E, Director
Shlevin Harold H., Director
Brem Henry, Director
ELDRED KARY, Director
LEWIS JOEL, President and CEO
CARSON BENJAMIN SR, Director

How to read Form 4 transaction codes